The CDMO Capacity Crunch With Discovery Labs' Audrey Greenberg and Iovance Biotherapeutics' Sumit Verma
Business Of Biotech
00:00
Gene Therapy
Mongol: Cell and gene therapy has been emerging for quite some time now. We're seeing an almost capacity crunch based on all of this data. And as more and more cell gene therapies come to market, CDMOs are continuing to become critical. In 2020 we broke all financing records, despite the challenges the industry faced from the COVID-19 pandemic.
Transcript
Play full episode
